bioprinting regenerative platform

BellaSeno’s Clinical Trial on 3D-Printed Breast Implants Shows Promising Early Results

Bioprinting firm BellaSeno has provided a public update on its ongoing clinical trial for resorbable breast scaffolding. The trial uses patients’ own fat with a 3D-printed scaffold, which gradually reabsorbs…

Featured

Bioprinter Maker Rokit Prepares for Korean IPO

Leading bioprinter manufacturer Rokit Healthcare is gearing up for its Initial Public Offering (IPO) as early as July 2021. In March 2021, the South Korean company announced it is preparing…